NRIXNurix Therapeutics Inc
NRIX
Nurix Therapeutics Inc649
Mkt Cap
$1.73BVolume
688,932.0052W High
$22.5052W Low
$8.20PE Ratio
-5.29NRIX Fundamentals
Price
$16.81Prev Close
$16.70Open
$16.7350D MA
$15.84Beta
1.63Avg. Volume
1.25MEPS (Annual)
-$3.05P/B
3.59Rev/Employee
$264,921.14$995.06
Houte Hans Van Sells 2,388 Shares of Nurix Therapeutics (NASDAQ:NRIX) Stock
Nurix Therapeutics, Inc. (NASDAQ:NRIX - Get Free Report) CFO Houte Hans Van sold 2,388 shares of the company's stock in a transaction that occurred on Thursday, April 30th. The shares were sold at an...
MarketBeat·12h ago
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Nurix Therapeutics, Inc. (NASDAQ:NRIX - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the fifteen analysts that are currently covering the firm, Marketbeat Ratings...
MarketBeat·16h ago
Nurix Therapeutics (NASDAQ:NRIX) CFO Houte Hans Van Sells 2,388 Shares
Nurix Therapeutics, Inc. (NASDAQ:NRIX - Get Free Report) CFO Houte Hans Van sold 2,388 shares of the firm's stock in a transaction dated Thursday, April 30th. The shares were sold at an average price...
MarketBeat·24h ago
Insider Selling: Nurix Therapeutics (NASDAQ:NRIX) Insider Sells 3,214 Shares of Stock
Nurix Therapeutics, Inc. (NASDAQ:NRIX - Get Free Report) insider Gwenn Hansen sold 3,214 shares of Nurix Therapeutics stock in a transaction dated Thursday, April 30th. The stock was sold at an...
MarketBeat·24h ago
Pictet Asset Management Holding SA Acquires 1,487,060 Shares of Nurix Therapeutics, Inc. $NRIX
Pictet Asset Management Holding SA lifted its holdings in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 75.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,467,600 shares of the company's...
MarketBeat·3d ago
Nurix Therapeutics (NASDAQ:NRIX) Receives Buy Rating from HC Wainwright
HC Wainwright reissued a "buy" rating and set a $32.00 price target on shares of Nurix Therapeutics in a research report on Monday...
MarketBeat·4d ago
Needham & Company LLC Reiterates Buy Rating for Nurix Therapeutics (NASDAQ:NRIX)
Needham & Company LLC reiterated a "buy" rating and issued a $26.00 price objective on shares of Nurix Therapeutics in a research note on Thursday...
MarketBeat·8d ago
Sumitomo Mitsui Trust Group Inc. Sells 266,925 Shares of Nurix Therapeutics, Inc. $NRIX
Sumitomo Mitsui Trust Group Inc. trimmed its position in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 17.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1...
MarketBeat·15d ago
Q2 EPS Estimate for Nurix Therapeutics Lifted by Analyst
Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) - HC Wainwright raised their Q2 2026 earnings estimates for shares of Nurix Therapeutics in a report issued on Friday, April 10th. HC Wainwright analyst R. Burns now forecasts that the company will earn ($0.73) per share for the quarter, up from t...
MarketBeat·18d ago
Does Nurix Therapeutics (NRIX) Have the Potential to Rally 85.84% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 85.8% in Nurix Therapeutics (NRIX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks·21d ago
<
1
2
...
>